國立虎尾科技大學 |

Metal-Organic Nanosensitizers for Drug Delivery and Cancer Therapy.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	Metal-Organic Nanosensitizers for Drug Delivery and Cancer Therapy./
Author:	Luo, Taokun.
Description:	1 online resource (263 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 85-02, Section: B.
Contained By:	Dissertations Abstracts International85-02B.
Subject:	Inorganic chemistry. -
Online resource:	click for full text (PQDT)
ISBN:	9798380143608

Metal-Organic Nanosensitizers for Drug Delivery and Cancer Therapy.
Luo, Taokun.

Metal-Organic Nanosensitizers for Drug Delivery and Cancer Therapy. - 1 online resource (263 pages)

Source: Dissertations Abstracts International, Volume: 85-02, Section: B.

Thesis (Ph.D.)--The University of Chicago, 2023.

Includes bibliographical references

Metal-organic nanosensitizers (MONs), including nanoscale metal-organic frameworks (nMOFs) and nanoscale metal-organic layers (nMOLs), are emerging nanoplatforms for biomedical applications, including photodynamic therapy (PDT), radiotherapy-radiodynamic therapy (RT-RDT), immunotherapy, sonodynamic therapy, photothermal therapy (PTT), drug delivery, imaging, and sensing. MON is a crystalline, porous, and supramolecular material consisting of bridging organic molecules (ligands) and metal or metal-oxo nodes (primary or secondary building units). MONs can achieve efficient mass transport for drug delivery and energy transfer to sensitize the generation of reactive oxygen species (ROS), respectively. Because of the component hierarchy in MONs, we can incorporate photosensitizing molecules into the ligands for PDT or stabilize unstable drugs by framework rigidity. We can use heavy metals in the secondary building units (SBUs) to enhance radiotherapy (RT) or conjugate hydrophilic drugs to SBUs for a sustained release under physiological conditions. The insoluble, hydrophobic drugs can be loaded into the hydrophobic channels of MOFs for delivery or spatial isolation to avoid aggregation-induced quenching of photosensitizers (PSs).The research of MONs for drug delivery and cancer therapy is a cross-disciplinary research standing at the intersection of physics, chemistry, and biology. Physics is used to study the energy transfer and sensitization mechanisms as exemplified by how low-energy or high-energy photons interact with photosensitizers or heavy metal SBUs, respectively. Chemistry is used to efficiently synthesize and characterize MON materials with crystallinity, appropriate pore dimensions, and suitable particle sizes, and to modify MONs with suitable therapeutic motifs. Biology and immunology are used to identify target applications, analyze treatment outcomes, and inform MON optimization for enhanced biological effects.My Ph.D. thesis research further leveraged the properties of MON materials, such as the rigid framework, open channels, Lewis acidic SBUs, and material dimensionality to maximize their anticancer efficacy. Starting from molecular design and material engineering, my research interest gradually shifted to the biomedical applications of MONs and addressing the limitations of existing anticancer drugs, such as instability, limited water solubility, and poor pharmacokinetics. My graduate research demonstrates MONs as a powerful nanoplatform for rescuing unfavorable drug candidates to enhance cancer therapy, including PDT, RT-RDT, chemotherapy, and immunotherapy.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798380143608Subjects--Topical Terms:

1182077
Inorganic chemistry.
Subjects--Index Terms:

Cancer therapyIndex Terms--Genre/Form:

554714
Electronic books.

Metal-Organic Nanosensitizers for Drug Delivery and Cancer Therapy.
LDR:04016ntm a22004097 4500 001 1144282
005 20240531083818.5
006 m o d
007 cr mn ---uuuuu
008 250605s2023 xx obm 000 0 eng d
020 $a 9798380143608
035 $a (MiAaPQ)AAI30568269
035 $a AAI30568269
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Luo, Taokun. $3 1469260
245 1 0 $a Metal-Organic Nanosensitizers for Drug Delivery and Cancer Therapy.
264 0 $c 2023
300 $a 1 online resource (263 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-02, Section: B.
500 $a Advisor: Lin, Wenbin.
502 $a Thesis (Ph.D.)--The University of Chicago, 2023.
504 $a Includes bibliographical references
520 $a Metal-organic nanosensitizers (MONs), including nanoscale metal-organic frameworks (nMOFs) and nanoscale metal-organic layers (nMOLs), are emerging nanoplatforms for biomedical applications, including photodynamic therapy (PDT), radiotherapy-radiodynamic therapy (RT-RDT), immunotherapy, sonodynamic therapy, photothermal therapy (PTT), drug delivery, imaging, and sensing. MON is a crystalline, porous, and supramolecular material consisting of bridging organic molecules (ligands) and metal or metal-oxo nodes (primary or secondary building units). MONs can achieve efficient mass transport for drug delivery and energy transfer to sensitize the generation of reactive oxygen species (ROS), respectively. Because of the component hierarchy in MONs, we can incorporate photosensitizing molecules into the ligands for PDT or stabilize unstable drugs by framework rigidity. We can use heavy metals in the secondary building units (SBUs) to enhance radiotherapy (RT) or conjugate hydrophilic drugs to SBUs for a sustained release under physiological conditions. The insoluble, hydrophobic drugs can be loaded into the hydrophobic channels of MOFs for delivery or spatial isolation to avoid aggregation-induced quenching of photosensitizers (PSs).The research of MONs for drug delivery and cancer therapy is a cross-disciplinary research standing at the intersection of physics, chemistry, and biology. Physics is used to study the energy transfer and sensitization mechanisms as exemplified by how low-energy or high-energy photons interact with photosensitizers or heavy metal SBUs, respectively. Chemistry is used to efficiently synthesize and characterize MON materials with crystallinity, appropriate pore dimensions, and suitable particle sizes, and to modify MONs with suitable therapeutic motifs. Biology and immunology are used to identify target applications, analyze treatment outcomes, and inform MON optimization for enhanced biological effects.My Ph.D. thesis research further leveraged the properties of MON materials, such as the rigid framework, open channels, Lewis acidic SBUs, and material dimensionality to maximize their anticancer efficacy. Starting from molecular design and material engineering, my research interest gradually shifted to the biomedical applications of MONs and addressing the limitations of existing anticancer drugs, such as instability, limited water solubility, and poor pharmacokinetics. My graduate research demonstrates MONs as a powerful nanoplatform for rescuing unfavorable drug candidates to enhance cancer therapy, including PDT, RT-RDT, chemotherapy, and immunotherapy.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Inorganic chemistry. $3 1182077
650 4 $a Biochemistry. $3 582831
650 4 $a Oncology. $3 593951
653 $a Cancer therapy
653 $a Chemotherapy
653 $a Immunotherapy
653 $a Metal-organic framework
653 $a Photodynamic therapy
653 $a Radiotherapy
655 7 $a Electronic books. $2 local $3 554714
690 $a 0488
690 $a 0487
690 $a 0992
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a The University of Chicago. $b Chemistry. $3 1187113
773 0 $t Dissertations Abstracts International $g 85-02B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30568269 $z click for full text (PQDT)